Advertisement
Advertisement
U.S. Markets open in 8 hrs 2 mins
Advertisement
Advertisement
Advertisement
Advertisement

Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
23.09-0.76 (-3.19%)
As of 01:12PM CST. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in CNY

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/29/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 342.62
52 Week Low 317.08
50-Day Moving Average 322.17
200-Day Moving Average 327.88

Share Statistics

Avg Vol (3 month) 32.24M
Avg Vol (10 day) 31.86M
Shares Outstanding 5135.48M
Implied Shares Outstanding 6N/A
Float 852.57M
% Held by Insiders 163.98%
% Held by Institutions 15.51%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.3
Forward Annual Dividend Yield 41.27%
Trailing Annual Dividend Rate 30.30
Trailing Annual Dividend Yield 31.26%
5 Year Average Dividend Yield 4N/A
Payout Ratio 438.96%
Dividend Date 3N/A
Ex-Dividend Date 4May 25, 2021
Last Split Factor 21:1
Last Split Date 3May 27, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Mar 31, 2022

Profitability

Profit Margin 9.29%
Operating Margin (ttm)10.94%

Management Effectiveness

Return on Assets (ttm)4.15%
Return on Equity (ttm)7.33%

Income Statement

Revenue (ttm)1.11B
Revenue Per Share (ttm)8.29
Quarterly Revenue Growth (yoy)27.80%
Gross Profit (ttm)280.48M
EBITDA 161.56M
Net Income Avi to Common (ttm)102.69M
Diluted EPS (ttm)0.83
Quarterly Earnings Growth (yoy)5.00%

Balance Sheet

Total Cash (mrq)144.84M
Total Cash Per Share (mrq)1.11
Total Debt (mrq)272.62M
Total Debt/Equity (mrq)19.17
Current Ratio (mrq)1.01
Book Value Per Share (mrq)10.38

Cash Flow Statement

Operating Cash Flow (ttm)23.72M
Levered Free Cash Flow (ttm)-48.8M
Advertisement
Advertisement